• Clip
• Medical research >> Clinical Trials >> Cancer - Non-randomised studies >> Anthea - Interview 39 >> The drug company running the trials paid petrol money for people driving to the hospital, but Anthea would have taken part anyway.

Anthea was diagnosed with malignant melanoma in 2000. She has been in a randomised trial of treatment with interferon and is now in a phase 1 trial of a combination of drugs which attack the DNA of cancer cells.

• Medical research >> Clinical Trials >> Cancer drugs and radiotherapy - randomised trials >> Wendy - Interview 02 >> The extra side effects meant she had to give up work and lost money as a result. There was a lot of disruption to family life, but they found a new ro

Wendy was invited to take part in a chemotherapy trial after being diagnosed with bowel cancer. She decided to take part, and was allocated to the experimental group. She experienced quite severe side effects but continued to the end of the treatment.

• Medical research >> Clinical Trials >> Screening, prevention other medical interventions >> Sabiha - Interview 19 >> Sabiha would have used her own annual leave to cover time off work for trial appointments.

Sabiha took part in a trial of breast screening for younger women (under 50). More recently she volunteered for a trial of cholesterol-lowering drugs but was not eligible because her cholesterol level was too low.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> The offer of a generous expenses package was attractive to David, though looking back he feels it was fair compensation for his time and effort.

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.

• Medical research >> Clinical Trials >> Long term conditions >> David - Interview 34 >> The offer of a generous expenses package was attractive to David, though looking back he feels it was fair compensation for his time and effort.

David volunteered for a placebo-controlled trial of a new treatment derived from mouse DNA to improve asthma symptoms. He later discovered he was in the group taking a lower dose of the treatment, but he would not have minded being in the placebo group.